A scoping review examining measurement of anti-transgender stigma in low- and middle-income countries.

PLOS global public health Pub Date : 2025-04-30 eCollection Date: 2025-01-01 DOI:10.1371/journal.pgph.0004490
Tamar Goldenberg, Amanda E Tanner, Mohammed Sheikh Eldin Jibriel, Jennifer Toller Erausquin, Sulianie Mertus, Keenan A Phillips, Grayson K Rodgers, Clare Barrington
{"title":"A scoping review examining measurement of anti-transgender stigma in low- and middle-income countries.","authors":"Tamar Goldenberg, Amanda E Tanner, Mohammed Sheikh Eldin Jibriel, Jennifer Toller Erausquin, Sulianie Mertus, Keenan A Phillips, Grayson K Rodgers, Clare Barrington","doi":"10.1371/journal.pgph.0004490","DOIUrl":null,"url":null,"abstract":"<p><p>Globally, transgender and other gender diverse (trans) people experience widespread prejudice, discrimination, violence, and other forms of stigma, which contribute to negative health outcomes. Most anti-trans stigma research has been conducted in high-income countries. Measurement of anti-trans stigma in low- and middle-income countries (LMICs) is important for understanding and improving the health of trans populations globally. Accordingly, this scoping review explores the use of quantitative anti-trans stigma measures in LMICs. This scoping review follows the guidance of the PRISMA extension for Scoping Reviews (PRISMA-ScR) Checklist and examines empirical research with trans populations in LMICs published in English, Spanish, Arabic, and Russian between 2001-2024. Study eligibility criteria included: 1) trans study population, 2) LMIC study location, 3) quantitative or mixed-method study design, and 4) quantitative measurement of anti-trans stigma. The search yielded 82 articles (representing 65 unique studies) from 34 LMICs. Most articles were published since 2018. No articles focused exclusively on trans men. About 62% of articles included a primary focus on stigma; health outcomes primarily examined HIV and mental health. Nearly all articles (95%) measured enacted stigma; other forms of stigma (e.g., internalized and anticipated) were less commonly measured, and structural stigma was only measured in 4 articles. More than half of the articles (55%) measured stigma both broadly and within specific contexts (e.g., from family, in health care). More research exploring anti-trans stigma is needed, especially with trans-masculine and other gender diverse people, measuring outcomes beyond HIV and mental health, and measuring forms of stigma beyond enacted stigma. Expanding and improving measurement of anti-trans stigma in LMICs can improve our understanding of the mechanisms shaping health equity to inform context specific and tailored health interventions to support trans communities worldwide.</p>","PeriodicalId":74466,"journal":{"name":"PLOS global public health","volume":"5 4","pages":"e0004490"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12043131/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLOS global public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1371/journal.pgph.0004490","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Globally, transgender and other gender diverse (trans) people experience widespread prejudice, discrimination, violence, and other forms of stigma, which contribute to negative health outcomes. Most anti-trans stigma research has been conducted in high-income countries. Measurement of anti-trans stigma in low- and middle-income countries (LMICs) is important for understanding and improving the health of trans populations globally. Accordingly, this scoping review explores the use of quantitative anti-trans stigma measures in LMICs. This scoping review follows the guidance of the PRISMA extension for Scoping Reviews (PRISMA-ScR) Checklist and examines empirical research with trans populations in LMICs published in English, Spanish, Arabic, and Russian between 2001-2024. Study eligibility criteria included: 1) trans study population, 2) LMIC study location, 3) quantitative or mixed-method study design, and 4) quantitative measurement of anti-trans stigma. The search yielded 82 articles (representing 65 unique studies) from 34 LMICs. Most articles were published since 2018. No articles focused exclusively on trans men. About 62% of articles included a primary focus on stigma; health outcomes primarily examined HIV and mental health. Nearly all articles (95%) measured enacted stigma; other forms of stigma (e.g., internalized and anticipated) were less commonly measured, and structural stigma was only measured in 4 articles. More than half of the articles (55%) measured stigma both broadly and within specific contexts (e.g., from family, in health care). More research exploring anti-trans stigma is needed, especially with trans-masculine and other gender diverse people, measuring outcomes beyond HIV and mental health, and measuring forms of stigma beyond enacted stigma. Expanding and improving measurement of anti-trans stigma in LMICs can improve our understanding of the mechanisms shaping health equity to inform context specific and tailored health interventions to support trans communities worldwide.

对低收入和中等收入国家反跨性别污名测量的范围审查。
在全球范围内,跨性别者和其他性别多样化(跨性别者)遭受广泛的偏见、歧视、暴力和其他形式的污名,这些都造成了负面的健康后果。大多数反变性污名化研究都是在高收入国家进行的。在低收入和中等收入国家(LMICs)测量反跨性别污名对于了解和改善全球跨性别人群的健康非常重要。因此,这一范围审查探讨了在中低收入国家使用定量反反污名措施。该范围审查遵循PRISMA范围审查扩展(PRISMA- scr)清单的指导,并检查2001-2024年间以英语、西班牙语、阿拉伯语和俄语发表的关于中低收入国家跨性别人群的实证研究。研究资格标准包括:1)跨性别研究人群;2)低收入和中等收入人群研究地点;3)定量或混合方法研究设计;4)反跨性别污名的定量测量。检索结果来自34个低收入国家的82篇文章(代表65项独特的研究)。大多数文章发表于2018年以后。没有专门针对跨性别男性的文章。约62%的文章主要关注污名;健康结果主要检查艾滋病毒和心理健康。几乎所有的文章(95%)都测量了病耻感;其他形式的耻辱感(如内化和预期)较少被测量,结构性耻辱感仅在4篇文章中被测量。超过一半的文章(55%)广泛地和在特定情况下(例如,来自家庭,在卫生保健中)测量了耻辱。需要更多的研究来探索反跨性别者的耻辱,特别是针对跨性别男性和其他性别多样化的人,衡量艾滋病毒和心理健康以外的结果,以及衡量既定耻辱之外的耻辱形式。扩大和改进中低收入国家中反跨性别歧视的测量可以提高我们对形成卫生公平机制的理解,从而为具体情况和量身定制的卫生干预措施提供信息,以支持全世界的跨性别社区。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信